You are here

SBIR PHASE I,¿¿N43TR-20-1022 ""RESORB MEMBRANE INSERTS - ADVANCED CELL CULTURE INSERTS WITH BIODEGRADABLE MEMBRANES"" (POP:7/27/2020 TO 04/26/2021)

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 75N95020C00017
Agency Tracking Number: 75N95020C00017-0-9999-0
Amount: $225,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: 19
Solicitation Number: N/A
Timeline
Solicitation Year: 2019
Award Year: 2020
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
301 1ST STREET SW, SUITE 200
ROANOKE, VA 24011-1921
United States
DUNS: 627132913
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Lauren Costella
 (434) 220-9441
 costellal@lunainc.com
Business Contact
 Lauren Costella
Phone: (434) 220-9441
Email: costellal@lunainc.com
Research Institution
N/A
Abstract

In vitro models of cell and tissue behavior are essential to the development of medical products, and the models required continue to become more sophisticated. Alongside these advancements, there is a need for supporting advancements in the cultureware and technqiues available. Cell culture insert plates (CCIPs) provide significant utility in the creation of in vitro systems, yet no commercially available CCIP exists in which the permeable membrane is biodegradable. A suitable product that is broadly available would facilitate the establishment of methods, and reproducibility and translation of results would be improved. Luna Innovations thus proposes the development of RESORB membrane inserts. The CCIPs will utilize reproducible and biodegradable electrospun membranes, and the inserts will be designed for ease of assembly. The effort is expected to result in a scalable, cost-effective, and validated CCIP solution available for standardized cell culture use. The proposed Phase I program has objectives aimed at demonstrating the feasibility of the membrane inserts, and the novel production and assembly thereof, for advanced cell culture applications. The Phase I program is expected to establish a foundation for scale-up and commercialization in Phase II.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government